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Background: Individual studies have reported different results regarding the association of HLA alleles with RA in
Chinese populations. This study was performed to systematically summarize results on the association of HLA-DRB1
with rheumatoid arthritis (RA) in China.
Methods: We examined the case–control studies concerned about the relationship between HLA-DRB1and RA and
differences of clinical and laboratory parameters between the HLA-DR4 (DR4)+ and DR4- in RA patients in Chinese
populations. Odds ratios (ORs) and weighted mean difference (WMD) with corresponding 95% confidence intervals
(CI) was used to describe the relationship.
Results: 22 studies with 1690 cases and 1793 controls were included. Chinese populations with RA had significantly
higher frequencies of HLA-DRB1*04, *0401, *0404, *0405 and *0410 than controls (ORDRB1*04 =4.19, 95% CI =3.44–5.11,
p<0.00001; ORDRB1*0401 =2.53, 95% CI =1.54–4.16, p=0.0003; ORDRB1*0404 =2.28, 95% CI =1.28–4.06, p=0.005;
ORDRB1*0405=3.71, 95% CI =2.52–5.45, p<0.00001; ORDRB1*0410 =2.99, 95% CI =1.25–7.14, p=0.01respectively).
As to laboratory parameters, Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Rheumatoid factor
(RF), Anti-cyclic citrullinated peptide antibodies (Anti-CCP ) in patients with DR4+ were higher than patients
with DR4- (WMD=0.26, 95% CI =0.15–0.37, p<0.00001; WMD = 0.26, 95% CI =0.12–0.41, p=0.0005; WMD = 0.44,
95% CI =0.23–0.65, p<0.00001; WMD = 0.58, 95% CI =0.24–0.91, p=0.0007 respectively). As to clinical features,
there was no difference in duration of morning stiffness, number of swollen joints, number of joint tenderness,
X-ray phases and joint function between the DR4+ and DR4- in RA patients.
Conclusions: It was found that HLA-DRB1*04, *0401, *0404, *0405 and *0410 are risk factors for RA in Chinese
populations. ESR, CRP, RF, Anti-CCP are different between the DR4+ and DR4- in RA patients in Chinese
populations, while there’s no difference for indexes of clinical features.
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RA is an autoimmune disease characterized by chronic in-
flammation of the joints, which may lead to joint destruc-
tion and disability. It is the common chronic inflammatory
rheumatic disease in the world, with prevalence estimates
of 0.25% to 0.5% [1]. Previous literature suggests that
people with rheumatoid arthritis may live 10–15 years less
than their healthy counterparts [2]. RA is a complex
polygenic disease of unknown etiology. However, genetic* Correspondence: 4830380@163.com
3Department of Dermatology, the third affiliated hospital of Guangxi
Medical University, 13 Dancun Road, Nanning 530031, Guangxi, People’s
Republic of China
Full list of author information is available at the end of the article
© 2013 Yang et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orvariation is believed to be important in determining the
susceptibility of RA. It was proven to be associated with
(histocompatibility locus antigen) HLA region strongly,
especially with HLA-DRB1 alleles [3].
HLA-DRB1 alleles encode (70Q(R)K(R)RAA74) encod-
ing the shared epitope (SE) (RAA amino acid pattern in
positions 72 to 74 of the third hypervariable region of the
DRβ1 chain) are associated with RA susceptibility [4]. SE
contains HLA-DRB1 alleles representing significant gen-
etic risk factor for RA. Many studies have attempted to
clarify the relationship between HLA-DRB1 and RA, but
there has been no definite consensus to date in Chinese
populations. Due to the relatively small numbers ofd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patients, the results are different in many studies. Well-
designed meta-analyses of Caucasian and American popu-
lations showed that there was a strong association between
HLA-DRB1 and RA susceptibility and severity [5].
Individual studies have reported different results regard-
ing the association of HLA alleles with RA in Chinese
populations. Some have reported that the frequency of the
HLA-DRB1*0401 and *0405 alleles are significantly in-
creased in RA patients, whereas others have found no as-
sociations [6,7]. Moreover, there were controversial results
about differences of clinical and laboratory parameters be-
tween the DR4+ and DR4- in RA patients [8,9].
This study was performed to systematically summarize
the association between Chinese with RA and HLA-DRB1
alleles. It was also performed to investigate the differences
of clinical and laboratory parameters between the DR4+
and DR4- in RA patients. The frequency of HLA-DRB1
alleles varies according to ethnic and racial back-
ground, with some alleles being extremely rare. There-
fore, articles were not required to identify all alleles for
inclusion.
Methods
Literature search and selection
The following databases: Cochrane Library, PubMed,
Embase, Chinese BioMedical Literature Database (CBM),Figure 1 Selection process for the studies included in the Meta-analyChina National Knowledge Infrastructure (CNKI), WANFANG
and Chinese Social Sciences Citation Index(VIP) databases
were searched for available articles without language re-
strictions. The index terms that we used were: (“human
leukocyte antigen” or “HLA”) and (“rheumatoid arthritis” or
“RA”) and (“Chinese” or “China”). Last query was updated
on 31 March, 2013. References of retrieved articles were
cross-searched to identify any studies missed by the
electronic search strategies.
Inclusion criteria
The studies which were fit into the meta-analysis was re-
quired to meet the following criteria: (1) the articles
must be proven diagnosis of RA patients with standard
criteria of American College of Rheumatology (ACR) in
1987. (2) Study should be correlated with the RA and
HLA-DRB1 in Chinese populations. (3) Study must be
case–control design. (4) When multiple articles were
published by the same authors or institutions, the most re-
cent or informative single article was selected. (5) Articles
lacking original data for meta-analysis, review articles were
excluded.
Quality assessment of included studies
The quality of papers was independently assessed by two re-
viewers (Pan Yanbin and Tan Meile) based on the STROBE
quality score systems [10]. Quality scores ranged fromsis.
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and high grade respectively. Articles with quality scores of
10 or less were excluded. Any discrepancies between the
two reviewers were resolved by discussion and consult-
ation with a third reviewer.
Data extraction
Data for this meta-analysis were extracted by two inves-
tigators (Li Jianmin and Wu Lingyan) independently and
reached a consensus on the disagreement. Results would
be arbitrated by a third reviewer (Yang Meng) if there
were any disagreement. The extracted details included
first author, year of publication, geographical region,
study design, sample, source of cases and controls, fre-
quency of HLA-DRB1 alleles, number of cases and con-
trols, clinical feature, laboratory index and detection
methods. The X-ray phases was according to standard of
Steinbrocker classification for the joint function and
joint function was measured by justification of triaxial
goniometer. These geographical populations can be clas-
sified into northern Han Chinese (N-Han) and southern
Han Chinese (S-Han), with the Yangtze River used as aTable 1 Main characteristics of the 22 studies included in the
Author
(reference)
Year Region Source of
cases
S
Ye SX [13] 1989 Liaoning Hospital-based Pop
Molkentin, J [14] 1993 Shanghai Hospital-based Pop
Zhu NS [15] 1994 Shanghai Hospital-based Pop
Wang BL [16] 1996 Anhui Hospital-based Pop
Xiao Z [17] 1997 Inner Mongolia Hospital-based Pop
Zhao Y [18] 1997 Beijing Hospital-based Pop
Gu JR [19] 1998 Guangdong Hospital-based Pop
Yuan GH [8] 1998 Beijing Hospital-based Pop
Zhang JQ [20] 1999 Hebei Hospital-based Pop
Liu QH [6] 2000 Hubei Hospital-based Pop
Wu H [21] 2001 Hunan Hospital-based Pop
Lin L[22] 2001 Guangdong Hospital-based Pop
Liu YJ [23] 2002 Guizhou Hospital-based Pop
Li XF [9] 2003 Shandong Hospital-based Pop
Zhang SL[24] 2003 Fujian Hospital-based Pop
Su Y [25] 2004 Beijing Hospital-based Ho
Duan JM [26] 2005 Anhui Hospital-based Pop
Zhang HW [7] 2005 Guangdong Hospital-based Pop
Chen CP [27] 2010 Shanxi Hospital-based Pop
Wang CF [28] 2010 Gansu Hospital-based Pop
Chang ZF [29] 2012 Inner Mongolia Hospital-based Pop
Shi YM [30] 2012 Xinjiang Hospital-based Pop
‘PCR-SSP’ stands for Polymerase Chain Reaction-Sequence-Specific Primers, ‘PCR-RFL
Phism and ‘NS’ corresponds to not stated.geographical boundary. In the subgroup analysis, sub-
jects of all included studies were divided into the south-
erners and northerners of China due to significantly
geographic variation in Chinese populations.
Statistical analysis
Meta-analysis was performed using the Review Manager
version 5.2 (provided by The Cochrane Collaboration)
and STATA package version 12.0 (Stata Corporation,
College Station, TX, USA). Dichotomous data were re-
ported as OR (calculated by chi-square test) whereas
continuous data were reported as WMD ± standard de-
viation (SD) (calculated by T test). The pooled OR or
WMD together with the 95% confidence interval (CIs)
were used for assessing the strength of association. The
heterogeneity among studies was judged by I [2] statis-
tics. It ranges between 0 and 100% and I [2] values of
25, 50 and 75% were defined as low, moderate and high
estimates, respectively. When a significant I [2] >50% in-
dicated heterogeneity across studies, the random effects
model was used for meta-analysis, or else the fixed ef-











ulation-based NS 39 100 22
ulation-based PCR-SSP 23 21 26
ulation-based PCR-RFLP 95 130 24
ulation-based PCR-SSP 30 30 17
ulation-based NS 41 50 16
ulation-based PCR-SSP 86 106 21
ulation-based PCR-SSP 47 108 23
ulation-based PCR-RFLP 35 100 23
ulation-based PCR-SSP 180 100 25
ulation-based PCR-SSP 78 126 26
ulation-based PCR-SSP 105 76 32
ulation-based PCR-SSP 117 100 21
ulation-based PCR-SSP 35 51 22
ulation-based PCR-SSP 132 130 31
ulation-based PCR-SSP 98 100 21
spital-based PCR-SSP 136 79 24
ulation-based PCR-SSP 25 77 23
ulation-based PCR-SSP 22 31 22
ulation-based PCR-SSP 42 14 21
ulation-based PCR-SSP 27 46 21
ulation-based PCR-SSP 140 100 23
ulation-based PCR-SSP 157 118 21
P’ stands for Polymerase Chain Reaction-Restriction Fragment Length Polymor
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the potential publication bias was assessed by the Begg's
funnel plot and Egger's test [12]. Statistical significance
was considered when the P value of the test was <0.05.
All P values were two-sided.
Results
With our inclusion criteria, a total of 489 references
were retrieved for initial review using search strategies
as described. 239 citations were excluded from analysis
after the first screening based on abstracts or titles. After
exclusion of the articles that did not meet the inclusion
criteria, we identified 40 potential studies for detail
evaluation. Upon further review, 18 articles were elimi-
nated due to the following reasons: 3 studies overlappedTable 2 Summary of the meta-analysis findings of the associa
Polymorphisms Eligible studies RA Case n/N Control n/N
HLA–DRB1*04 12 489/965 240/1166
Northerner 5 248/528 111/566
Southerner 7 241/437 129/600
HLA–DRB1*0401 10 54/733 24/814
Northerner 5 31/397 16/390
Southerner 5 23/336 8/424
HLA–DRB1*0402 1 4/287 2/196
HLA–DRB1*0404 10 44/733 19/814
Northerner 5 31/397 10/390
Southerner 5 13/336 9/424
HLA–DRB1*0405 11 240/913 91/914
Northerner 6 142/577 54/490
Southerner 5 98/336 37/424
HLA–DRB1*0408 9 16/620 7/757
Northerner 5 13/295 5/350
Southerner 4 3/325 2/407
HLA–DRB1*0409 8 8/578 3/743
Northerner 4 6/253 2/336 3
Southerner 4 2/325 1/407 1
HLA–DRB1*0410 8 15/578 7/743
Northerner 4 4/253 1/336 3
Southerner 4 11/325 6/407
HLA–DRB1*01 8 45/557 45/785
Northerner 4 25/292 27/436
Southerner 4 20/265 18/349
HLA–DRB1*0101 1 9/245 9/356
HLA–DRB1*0102 1 4/245 5/356
HLA–DRB1*10 5 20/417 18/538
Northerner 3 16/253 14/336
Southerner 2 4/164 4/202
‘n’ stands for number of positive events, ‘N’ stands for number of total events.with others; 15 studies didn’t provide sufficient data about
HLA-DRB1 alleles frequency on cases and/or controls or
lacked clinical feature or laboratory indexes data to create
for meta-analysis. Finally, 22 studies performed on the as-
sociation of HLA-DRB1 with rheumatoid arthritis in
Chinese populations were included and analyzed. Selec-
tion process for the studies included in the meta-
analysis is summarized in Figure 1. The main features
of eligible studies in our meta-analysis are summa-
rized in Tables 1.
Association of DRB1 alleles with RA susceptibility
These 22 case–control studies selected included a total of
1690 RA cases and 1793 healthy controls. A total of 12 al-
leles were assayed in the studies: HLA-DRB1*01, *0101,tion between HLA-DRB1 alleles and RA
OR (95% CI) p–value Heterogeneity test Effect model
4.19 (3.44 – 5.11) <0.00001 p=0.93, I [2]=0% Fixed
3.67 (2.78 – 4.84) <0.00001 p=0.96, I [2]=0%
4.83 (3.64 – 6.4) <0.00001 p=0.86, I [2]=0%
2.53 (1.54 – 4.16) 0.0003 p=0.91, I [2]=0% Fixed
2 (1.06 – 3.79) 0.003 p=0.87, I [2]=0%
3.59 (1.6 – 8.06) 0.002 p=0.78, I [2]=0%
1.41 (0.31 – 6.42) 0.65 p=0.75, I [2]=0% Fixed
2.28 (1.28 – 4.06) 0.005 p=0.91, I [2]=0% Fixed
2.46 (1.14 – 5.28) 0.02 p=0.75, I [2]=0%
2.06 (0.85 – 4.94) 0.11 p=0.72, I [2]=0%
3.71 (2.52 – 5.45) <0.00001 p=0.10, I [2]=38% Random
3.17 (1.84 – 5.48) <0.00001 p=0.11, I [2]=44%
4.56 (2.69 – 7.73) <0.00001 p=0.26, I [2]=25%
2.24 (0.94 – 5.34) 0.07 p=0.77, I [2]=0% Fixed
2.27 (0.82 – 6.29) 0.12 p=0.51, I [2]=0%
2.18 (0.42 – 11.3) 0.35 p=0.63, I [2]=0%
2.78 (0.92 – 8.42) 0.07 p=0.43, I [2]=0% Fixed
.28 (0.85 – 12.57) 0.08 p=0.22, I [2]=35%
.91 (0.26 – 13.95) 0.53 p=0.93, I [2]=0%
2.99 (1.25 – 7.14) 0.01 p=0.93, I [2]=0% Fixed
.96 (0.71 – 22.12) 0.12 p=0.92, I [2]=0%
2.7 (0.98 – 7.42) 0.05 p=0.58, I [2]=0%
1.35 (0.87 – 2.11) 0.18 p=0.87, I [2]=0% Fixed
1.45 (0.8 – 2.61) 0.22 p=0.63, I [2]=0%
1.23 (0.62 – 2.45) 0.55 p=0.72, I [2]=0%
1.48 (0.57 – 3.84) 0.42 p=0.92, I [2]=0% Fixed
1.08 (0.3 – 3.9) 0.9 p=0.95, I [2]=0% Fixed
1.3 (0.67 – 2.52) 0.43 p=0.69, I [2]=0% Fixed
1.34 (0.64 – 2.84) 0.44 p=0.44, I [2]=0%
1.17 (0.29 – 4.71) 0.82 p=0.43, I [2]=0%
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*0408, *0409 and *0410(DR4); HLA-DRB1*10(DR10). The
most common polymorphisms were DRB1*0405. Summary
of the meta-analysis findings of the association between
HLA-DRB1 alleles and RA is shown in Table 2.
The ORs showed that Chinese patients with RA had sig-
nificantly higher frequencies of HLA-DRB1*04 (Figure 2),
*0401, *0404, *0405 (Figure 3) and *0410 (ORDRB1*04 =
4.19, 95% CI =3.44–5.11, p<0.00001; ORDRB1*0401 =2.53,
95% CI =1.54–4.16, p=0.0003; ORDRB1*0404=2.28, 95%
CI =1.28–4.06, p=0.005; ORDRB1*0405=3.71,95%CI=2.52–
5.45, p<0.00001; ORDRB1*0410=2.99,95%CI=1.25–7.14, p=0.01
respectively).
However, HLA-DRB1*0408, *0409, *01, *0101, *0102 and
*10 showed no association with susceptibility to RA in
Chinese populations (ORDRB1*0408 =2.24, 95%CI =0.94–5.34,
p=0.07; ORDRB1*0409 =2.24, 95%CI =0.94–5.34, p=0.07;
ORDRB1*01 =1.35, 95%CI =0.87–2.11, p=0.18; ORDRB1*0101 =
1.48, 95% CI=0.57–3.84, p=0.42; ORDRB1*0102=1.08,95%
CI=0.3–3.9, p=0.9; ORDRB1*10=1.3, 95% CI =0.67–2.52,
p=0.43 respectively).
Results of subgroup analysis showed that there was a
positive association between DRB1*0404 and susceptibility
to RA in the northerners (OR=2.46, 95% CI=1.14–5.28),
but not in the southerners (OR =2.06, 95% CI=0.85–4.94).
Results of subgroup analysis showed that there was a
higher susceptibility of DRB1*04, *0401, *0405 in the south-
erners than in the northerners of China. No association
was found between DRB1*0408, *0409, *01,*0101, *0102Figure 2 Meta analysis of the association of HLA-DRB1*04 with rheumand *10 and susceptibility to RA both in the southerners
and northerners of China.
Differences of clinical and laboratory parameters between
the DR4+ and DR4- in RA patients
Chi-square test or T test was took to evaluate the balance
of average age, gender and disease duration of included
studies, there were not obvious imbalance of the baseline
for them. We contacted the original authors to get data of
treatments and sensitivity of the scale of X-ray. There
were not obvious imbalance of the baseline for them too.
A summary of the meta-analysis findings of the associ-
ation between DR4+ and DR4-in RA patients is shown in
Table 3. As to laboratory parameters, ESR (Figure 4), CRP
(Figure 5), RF, Anti-CCP in patients with DR4+ were higher
than patients with DR4- (WMD=0.26, 95%CI =0.15–0.37,
p<0.00001; WMD = 0.26, 95%CI =0.12–0.41, p=0.0005;
WMD = 0.44, 95%CI =0.23–0.65, p<0.00001; WMD = 0.58,
95% CI =0.24–0.91, p=0.0007 respectively).
As to clinical features, there was no difference in dur-
ation of morning stiffness, number of swollen joints and
number of joint tenderness between the DR4+ and DR4-
in RA patients (WMD=0.23,95% CI=−0.01–0.48, p=0.06;
WMD=0.13,95%CI=−0.00–0.26, p=0.05;WMD=0.08,95%
CI=−0.06–0.23, p=0.25 respectively). There was no differ-
ence in X-ray phases (Figure 6) and joint function between
the DR4+ and DR4- in RA patients (OR =0.93, 95%
CI =0.66–1.29, p=0.65; OR = 0.89, 95%CI =0.65–1.23,
p=0.6 respectively).atoid arthritis in Chinese populations.
Table 3 Summary of the meta-analysis findings of the differences of clinical and laboratory parameters between the





Case (N or n/N)
DR4+
Control







ESR 10 Yes 590 762 0.26 (0.15, 0.37) <0.00001 p=0.16, I [2]=31% Fixed
Northerner 7 Yes 458 562 0.22 [0.09, 0.35] 0.0007 p=0.13, I [2]=40%
Southerner 3 Yes 132 200 0.39 [0.17, 0.61] 0.0006 p=0.16, I [2]=31%
CRP 6 Yes 325 436 0.26 [0.12, 0.41] 0.0005 p=0.11, I [2]=44% Fixed
RF 4 Yes 139 246 0.44 [0.23, 0.65] <0.00001 p=0.42, I [2]=0% Fixed
Anti-CCP 2 Yes 52 123 0.58 [0.24, 0.91] 0.0007 p=0.28, I [2]=15% Fixed
Duration of morning
stiffness
5 Yes 228 337 0.23 [−0.01, 0.48] 0.06 p=0.11, I [2]=47% Fixed
Number of swollen joints 7 Yes 414 527 0.13 [−0.00, 0.26] 0.05 p=0.29, I [2]=18% Fixed
Number of joint tenderness 6 Yes 368 437 0.08 [−0.06, 0.23] 0.25 p=0.67, I [2]=0% Fixed
X-ray phases 8 Yes 137/368* 142/365* 0.93 (0.66–1.29)’ 0.65 p=0.1, I [2]=42% Fixed
I ~ II 3 Yes 44/108* 63/135* 0.47 (0.26–0.87)’ 0.02 p=0.75, I [2]=0%
III ~ IV 5 Yes 93/260* 79/230* 1.27 (0.84–1.92)’ 0.25 p=0.26, I [2]=25%
Joint function 8 Yes 93/260* 79/230* 0.89 (0.65–1.23)’ 0.6 p=0.02, I [2]=58% Random
I ~ II 3 Yes 124/364* 182/463* 0.59 (0.35–1)’ 0.05 p=0.51, I [2]=0%
III ~ IV 5 Yes 56/149* 96/170* 1.14 (0.76–1.69)’ 0.88 p=0.02, I [2]=65%
‘n’ stands for number of positive events, ‘N’ stands for number of total events.
* n/N.
‘OR (95%CI).
Figure 3 Meta analysis of the association of HLA-DRB1*0405 with rheumatoid arthritis in Chinese populations.
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Figure 4 Meta analysis of the differences of ESR between the DR4+ and DR4- in RA patients.
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positive association between DRB1*0404 and X-ray phases
to RA in phases I~II (OR=0.47, 95%CI=0.26–0.87), but not
in the phases III~IV (OR =1.27, 95%CI=0.84, 1.92).Sensitivity analysis and publication bias
The sensitivity analyses revealed that none of the stud-
ies significantly affected the pooled ORs and CIs.When
each study is sequentially removed and the pooled ORs
remain almost the same. The funnel plot to detect
publication bias showed relatively symmetric for most
alleles (e.g. Figure 7 Funnel plot for the association of
HLA-DRB1*0405 with rheumatoid arthritis in Chinese
populations), except for ESR. Moreover, the regression
asymmetry test did not reveal significant evidence for
publication bias (Egger p=0.348).Figure 5 Meta analysis of the differences of CRP between the DR4+ aDiscussion
In this meta-analysis, 12 HLA-DRB1 polymorphisms
were addressed and evaluated. Our meta-analysis results
showed that there was a positive association between
HLA-DRB1*04, *0401, *0404, *0405 and *0410 and sus-
ceptibility to RA, which indicated that they may be po-
tential risk factors for RA in Chinese populations. The
SE hypothesis indicated that these genes encoding the
third hypervariable region of the DR antigen amino acid
and the sequence are QKRAA, or QRRAA or RRRAA
[31]. It is based on the assumption that class II mole-
cules are directly involved in the etiology and pathogen-
esis of autoimmune disease. The initiation of an immune
response requires T cell activation, and such activation
requires the presence of both antigen and HLA-DRB1
on antigen presenting cells. Many current studies as-
sume that some direct physical interaction between classnd DR4- in RA patients.
Figure 6 Meta analysis of the differences of X-ray phases between the DR4+ and DR4- in RA patients.
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in this process. The SE hypothesis assumes that struc-
tural differences between class II molecules can influ-
ence the interaction, either at the level of antigen
presentation or during T cell differentiation in the thy-
mus [32].
Teller found that the “shared” DRB1 amino acid se-
quence was relatively infrequent in the Hispanic American
patients with RA which may not be useful in other ethnic
groups [33]. This study may supplement data of associ-
ation of DRB1 in Chinese populations.
In the subgroup analysis by geographic distribution,
results showed that DRB1*0404 might be a potential
risk factor for RA in the northerners of China rather
than southerners. It showed that there was a higherFigure 7 Funnel plot for the association of HLA-DRB1*0405
with rheumatoid arthritis in Chinese populations.susceptibility of DRB1*04, *0401, *0405 in the south-
erners than in the northerners of China. However as
to DRB1*0404, it had an opposite result. All these
may suggest a possible role of geographic differences
in genetic backgrounds and the environment they
lived in.
Summary of the meta-analysis findings of the associ-
ation between DR4+ and DR4-in RA patients was shown
in Table 3. As to laboratory parameters, ESR, CRP, RF,
Anti-CCP in patients with DR4+ were higher which in-
dicate the serious condition, poor prognosis and diffi-
culty to alleviate in patients with DR4+. As to clinical
features, there was no difference in duration of morning
stiffness, number of swollen joints, joint function and
number of joint tenderness between the DR4+ and DR4-
in RA patients, the mechanism about it should be fur-
ther explored.
Results of subgroup analysis show that there was a posi-
tive association between DRB1*0404 and X-ray phases to
RA in phases I~II, but not in the phases III~IV. It suggests
that the DR4+ patients with bone erosion may occur at an
early stage.
We also found that the most common polymorphism
was DRB1*0405 in Chinese population. While DRB1*0401
and DRB1*0402 were the most common polymorphismss
in white population and Jews [34]. The role of the various
subtypes in RA susceptibility were different in different
populations and the constitute of susceptibility and non-
susceptibility subsets were also different. Therefore, stud-
ies of RA-related genes should be on the basis of region,
nationality and the sample should be expanded and more
associated genes should be tested at the same time. We
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comprehensive analysis of the patients with RA. This will
benefit to the revealment of the pathogenesis, early diag-
nosis and the prevention and control of RA.
Several limitations of the current studies could not be
ignored. First, although we did not detect significant
publication bias except for ESR between studies, it is un-
certain whether the cases are comparably representative,
and they are observational studies, more prone to many
biases than prospective randomized controlled studies
[35]. We found publication bias for ESR, there may be
missing information which reflected “negative” or more
conservative association of ESR with DR4.It need more
samples to validate the reliability of our conclusions.
Secondly, we distinguish the geographical populations
into N-Han and S-Han with the Yangtze River serving as
a geographical boundary, however the way to distinguish
them is complicated which may lead to an inflated rate
of false-positive results [36]. Thirdly, we were not able to
perform subgroup for each polymorphism due to the
limited number of published studies. Fourthly, our sys-
tematic review was based on unadjusted data, as the al-
leles information stratified for the main confounding
variables was not available in the original papers. Al-
though we actively contacted with the authors, we did
not got a comprehensive set of data. Fifthly, we were not
able to stratify our analyses according to the presence of
anti-CCP antibodies. Chun-Lai found that different
DRB1 SE alleles are common in Asian patients. These
alleles confer a significant risk of developing ACPA-
positive RA, but not ACPA-negative RA (i.e., in three
Asian populations from Malaysia) [37]. Fisher et al.
found that HLA-DRB1 SE was associated with both
ACPA positive and negative RA, in a Korean population,
but that there was a particularly strong interaction of
smoking and HLA- DRB1 SE alleles that associated with
ACPA fine-specificity [38,39]. Finally, although all cases
and controls of each study were well defined with similar
inclusion criteria, there may be potential factors that
were not taken into account that may have influenced
our results.
As not enough studies were available in this field and
current evidence remains limited. Therefore, it should be
emphasised the necessity to conduct more studies with an
adequate methodological quality, properly controlling for
possible confounds in order to obtain a more valid result.
Conclusions
Our meta-analysis shows that HLA-DRB1*04, *0401, *0404,
*0405 and *0410 are associated with RA, while DRB1*0405
is the most common polymorphism in Chinese populations.
ESR, CRP, RF, Anti-CCP in patients with DR4+ were higher
than DR4-, whereas there’s no difference for indexes of clin-
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